<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Publications - Bobby Zhao Sheng Lo</title>
  <link rel="stylesheet" href="style.css">
  <style>
    body { font-family: 'Segoe UI', sans-serif; max-width: 1000px; margin: auto; }
    .metrics { float: right; width: 250px; background: #f5f5f5; padding: 15px; margin: 20px; border: 1px solid #ccc; }
    .pubs { margin-right: 280px; padding: 20px; }
    h1, h2 { color: #333; }
    ul { list-style-type: none; padding-left: 0; }
    li { margin-bottom: 15px; }
    .nav-bar { list-style: none; display: flex; justify-content: center; padding: 10px; background-color: #e5dfd5; margin: 0; }
    .nav-bar li { margin: 0 20px; }
    .nav-bar a { text-decoration: none; color: #5a5148; font-weight: bold; }
    .nav-bar a:hover { text-decoration: underline; }
  </style>
</head>
<body>

  <!-- ✅ Navigation Bar -->
  <nav>
    <ul class="nav-bar">
      <li><a href="index.html">Home</a></li>
      <li><a href="publications.html">Publications</a></li>
    </ul>
  </nav>

  <h1>My Publications</h1>

  <div class="metrics">
    <h2>Scholar Metrics</h2>
    <ul>
      <li>Total citations: 1239</li>
      <li>h-index: 17</li>
      <li>i10-index: 21</li>
      <li><a href="https://scholar.google.com/citations?user=YrAJMdcAAAAJ" target="_blank">Google Scholar</a></li>
    </ul>
  </div>

  <div class="pubs">
    <h2>Peer-reviewed Publications</h2>
    <ul>
<li><strong>P0290 Predicting disease remission in Ulcerative Colitis patients-early results from the PRESAGER study</strong><br>Unknown authors (2025)<br><em></em></li>
<li><strong>Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial]</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>Building an AI Support Tool for Real-Time Ulcerative Colitis Diagnosis</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>The global evolution of inflammatory bowel disease across four epidemiologic stages</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>Clinical Outcomes After First-Line Anti-Tumor-Necrosis-Factor Treatment of Patients With Inflammatory Bowel Disease—A Prospective Multicenter Cohort Study</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>Building an AI Support Tool for Real-time Ulcerative Colitis Diagnosis</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>The disease course of elderly patients with Inflammatory Bowel Disease two years prior to their death</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>The first steps towards clinical application of artificial intelligence in inflammatory bowel diseases</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>P1240 Systematic review with meta-analysis: faecal microbiota transplantation as treatment of chronic pouchitis</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>P1174 The disease course of elderly patients with Inflammatory Bowel Disease two years prior to their death</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>P375 Histological activity predicts the risk of colectomy after biological treatment in biological-naive patients with Ulcerative Colitis</strong><br>Unknown authors (2024)<br><em></em></li>
<li><strong>The incidence and prevalence of paediatric-and adult-onset inflammatory bowel disease in Denmark during a 37-year period: a nationwide cohort study (1980–2017)</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>Identifying patients with inflammatory bowel disease in the Danish National Patient Register</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>Disease course and treatment outcomes of Crohn's disease patients with early or late surgery–a Danish nationwide cohort study from 1997 to 2015</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>Exploring the impact of COVID-19-related perceptions on psychological distress and quality of life in an international gastrointestinal cohort over time guided by the common …</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>Tu1715 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ON EFFICACY AND SAFETY OF PROBIOTIC TREATMENT WITH TRICHURIS SUIS OVA IN PATIENTS WITH ULCERATIVE COLITIS</strong><br>Unknown authors (2023)<br><em></em></li>
<li><strong>High accuracy in classifying endoscopic severity in ulcerative colitis using convolutional neural network</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>Survey uncovering variations in the management of primary sclerosing cholangitis across Europe</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>Histological inflammation in the endoscopically uninflamed mucosa is associated with worse outcomes in limited ulcerative colitis</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>P405 Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn’s Disease–preliminary results …</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>Improving the Real-time Classification of Disease Severity in Ulcerative Colitis: Artificial Intelligence as the Trigger for a Second Opinion</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease-preliminary results from …</strong><br>Unknown authors (2022)<br><em></em></li>
<li><strong>The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>Extending the common sense model to explore the impact of the fear of COVID-19 on quality of life in an international inflammatory bowel disease cohort</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>Artificial intelligence assisted assessment of endoscopic disease activity in inflammatory bowel disease</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>Deep Learning Surpasses Gastrointestinal Experts at Classifying Endoscopic Severity in Patients with Ulcerative Colitis</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>P610 Fear of COVID-19 among persons with Inflammatory Bowel Disease according to employment status, educational background and residential setting, as compared to persons with …</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>Sa081 FEAR OF COVID-19 AMONG IBD PATIENTS ACCORDING TO EMPLOYMENT STATUS, EDUCATION AND RESIDENCE AND COMPARED TO OTHER GI CONDITIONS</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>P162 Microscopic inflammation in limited Ulcerative Colitis at diagnosis: can a single histological feature predict prognosis?</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>AN INTERNATIONAL STUDY ON WELL-BEING OF PATIENTS WITH GASTROINTESTINAL DISORDERS DURING THE COVID19 PANDEMIC</strong><br>Unknown authors (2021)<br><em></em></li>
<li><strong>Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>Direct and indirect costs of inflammatory bowel disease: ten years of follow-up in a Danish population-based inception cohort</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>Validation of ulcerative colitis and Crohn’s disease and their phenotypes in the Danish National Patient Registry using a population-based cohort</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>Multistrain probiotic increases the gut microbiota diversity in obese pregnant women: results from a randomized, double-blind placebo-controlled study</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease: a Danish population-based inception cohort with 10 years of follow-up</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>Fecal microbiota transplantation for treatment of irritable bowel syndrome</strong><br>Unknown authors (2020)<br><em></em></li>
<li><strong>A 10-year follow-up study of the natural history of perianal Crohn’s disease in a Danish population-based inception cohort</strong><br>Unknown authors (2019)<br><em></em></li>
<li><strong>Paediatric onset inflammatory bowel disease is a distinct and aggressive phenotype—a comparative population‐based study</strong><br>Unknown authors (2019)<br><em></em></li>
<li><strong>Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort</strong><br>Unknown authors (2019)<br><em></em></li>
<li><strong>P743 Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based …</strong><br>Unknown authors (2019)<br><em></em></li>
<li><strong>DOP82 Direct and indirect costs of inflammatory bowel disease in the biological era; 10 years of follow-up in a Danish population-based inception cohort</strong><br>Unknown authors (2019)<br><em></em></li>
<li><strong>Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>Changes in disease behaviour and location in patients with Crohn’s disease after seven years of follow-up: a Danish population-based inception cohort</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory …</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>914-Fecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: Results from a randomized, double-blind placebo controlled study</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>P813 Occurrence, disease course and prognosis of perianal Crohn’s disease in a Danish population-based inception cohort—a 10-year follow-up study</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>DOP041 Surgery and hospitalisation in patients with inflammatory bowel disease; 10-year follow-up of a Danish population-based inception cohort</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>P786 The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohort</strong><br>Unknown authors (2018)<br><em></em></li>
<li><strong>Y-ECCO Literature Review: Bobby Zhao Sheng Lo Bobby Zhao Sheng Lo</strong><br>Unknown authors (2017)<br><em></em></li>
<li><strong>Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort</strong><br>Unknown authors (2016)<br><em></em></li>
<li><strong>Multi-strain Probiotic Increases the Gut Microbiota Diversity in Obese Pregnant Women: Results from a Randomized, Double-blind Placebo-controlled Study</strong><br>Unknown authors (n.d.)<br><em></em></li>

    </ul>
  </div>

</body>
</html>
